We Should Not Forget About Patients With Inflammatory Bowel Disease Who Received a COVID-19 Viral Vector Vaccine

Am J Gastroenterol. 2022 Aug 1;117(8):1329. doi: 10.14309/ajg.0000000000001791.

Authors

Megan Lutz¹, Mary S Hayney², Freddy Caldera¹

Affiliations

¹ Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA.
² School of Pharmacy, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA.

PMID: 35435853
DOI: 10.14309/ajg.0000000000001791

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19 Vaccines* / administration & dosage
COVID-19* / prevention & control
Humans
Inflammatory Bowel Diseases* / therapy
SARS-CoV-2

Substances

COVID-19 Vaccines